Well-designed Pd-L1 Tumor Immunotherapy - DL-Alanine CAS:302-72-7 99% – XD BIOCHEM
Well-designed Pd-L1 Tumor Immunotherapy - DL-Alanine CAS:302-72-7 99% – XD BIOCHEM Detail:
Catalog Number | XD90327 |
Product Name | DL-Alanine |
CAS | 302-72-7 |
Molecular Formula | C3H7NO2 |
Molecular Weight | 89.09 |
Storage Details | Ambient |
Harmonized Tariff Code | 29224985 |
Product Specification
Catalog Number | XD90327 |
Product Name | DL-Alanine |
CAS | 302-72-7 |
Molecular Formula | C3H7NO2 |
Molecular Weight | 89.09 |
Storage Details | Ambient |
Harmonized Tariff Code | 29224985 |
The effectiveness of antibiotic molecules in treating Pseudomonas aeruginosa pneumonia is reduced as a result of the dissemination of bacterial resistance. The existence of bacterial communication systems, such as quorum sensing, has provided new opportunities of treatment. Lactonases efficiently quench acyl-homoserine lactone-based bacterial quorum sensing, implicating these enzymes as potential new anti-Pseudomonas drugs that might be evaluated in pneumonia.The aim of the present study was to evaluate the ability of a lactonase called SsoPox-I to reduce the mortality of a rat P. aeruginosa pneumonia.To assess SsoPox-I-mediated quorum quenching, we first measured the activity of the virulence gene lasB, the synthesis of pyocianin, the proteolytic activity of a bacterial suspension and the formation of biofilm of a PAO1 strain grown in the presence of lactonase. In an acute lethal model of P. aeruginosa pneumonia in rats, we evaluated the effects of an early or deferred intra-tracheal treatment with SsoPox-I on the mortality, lung bacterial count and lung damage.SsoPox-I decreased PAO1 lasB virulence gene activity, pyocianin synthesis, proteolytic activity and biofilm formation. The early use of SsoPox-I reduced the mortality of rats with acute pneumonia from 75% to 20%. Histological lung damage was significantly reduced but the lung bacterial count was not modified by the treatment. A delayed treatment was associated with a non-significant reduction of mortality.These results demonstrate the protective effects of lactonase SsoPox-I in P. aeruginosa pneumonia and open the way for a future therapeutic use.
Product detail pictures:
Related Product Guide:
With our leading technology also as our spirit of innovation,mutual cooperation, benefits and development, we are going to build a prosperous future jointly with your esteemed company for Well-designed Pd-L1 Tumor Immunotherapy - DL-Alanine CAS:302-72-7 99% – XD BIOCHEM , The product will supply to all over the world, such as: Brunei, Madrid, Sydney, We look forward to hearing from you, whether you are a returning customer or a new one. We hope you will find what you are looking for here, if not, please contact us immediately. We pride ourselves on top notch customer service and response. Thank you for your business and support!
By Daniel Coppin from Sri Lanka - 2017.01.28 18:53
It is a very good, very rare business partners, looking forward to the next more perfect cooperation!
By Joa from Israel - 2018.08.12 12:27